| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_28e3113097dd6d28720572e47f2f2407 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2814
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5041
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5011 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 |
| filingDate |
2006-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_575c40ace8ce75e7900afa1200ec0d91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b0472040d424131603d06bae2b23866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb7ea2fe4d55a0f033335bc91c4cd891
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59435831e36bfbf991e7bfe2c95511ad |
| publicationDate |
2011-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1860185-B1 |
| titleOfInvention |
Screening method |
| abstract |
Disclosed are a compound capable of promoting or inhibiting the activity of a protein having the same or substantially the same amino acid sequence as that depicted in SEQ ID NO:1 or a salt of the compound; a compound capable of promoting or inhibiting the expression of the gene for the protein or a salt of the compound; an antisense polynucleotide comprising a nucleotide sequence complementary or substantially complementary to a nucleotide sequence of a polynucleotide encoding the protein or a partial peptide thereof or comprising a part of the nucleotide sequence; an antibody directed against the protein; and the like. The compound or salt thereof, antisense nucleotide, antibody or the like can be used as a prophylactic/therapeutic agent for a mental disease, a prolactin-related disease or the like. |
| priorityDate |
2005-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |